UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example Bundle: Fragmin-5000IE-Solution-SE-IS-MPD-BBDL

Fragmin® 5000 IE Injektionsvätska, lösning i förfylld spruta

MPID: SE-100001390-00010756
EURDID: 922

Full name: Fragmin® 5000 IE Injektionsvätska, lösning i förfylld spruta

- Invented name part: Fragmin®

- Strength part: 5000 IE

- Pharmaceutical dose form part: Injektionsvätska, lösning i förfylld spruta

Name usage: Swedish (Kingdom of Sweden)

Authorised dose form: Solution for injection in pre-filled syringe

Legal status of supply: Medicinal product subject to medical prescription

Domain: Human use

Resource status: Current

Product classification:

  • 100000093533 B01AB04

Marketing Authorisation 1 of 1

Authorisation number: 10756

Region: Kingdom of Sweden

Marketing authorisation holder: Pfizer AB

Identifier:

  • LOC-100006423

Status: Valid (1988-03-18)

Package 1 of 5

PCID:

Description:
Förfylld spruta, 10 st

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 1 Syringe

Package: 1 Box (Cardboard)

Containing:

Package: 10 Unit-dose blister (Plastic)

Containing:

Package: 1 Pre-filled syringe (Glass)

Containing: 1 Syringe

Manufactured Item

Dose form: Solution for injection

Unit of presentation: Syringe

Ingredient

Role: Active

Substance: dalteparin sodium

Concentration strength: quantity sufficient / 1 unit(s)

Reference strength:
dalteparin 5000 international unit(s) / 1 unit(s)

Package 2 of 5

PCID:

Description:
Förfylld spruta, 100 st

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 1 Syringe

Package: 1 Box (Cardboard)

Containing:

Package: 100 Unit-dose blister (Plastic)

Containing:

Package: 1 Pre-filled syringe (Glass)

Containing: 1 Syringe

Manufactured Item

Dose form: Solution for injection

Unit of presentation: Syringe

Ingredient

Role: Active

Substance: dalteparin sodium

Concentration strength: quantity sufficient / 1 unit(s)

Reference strength:
dalteparin 5000 international unit(s) / 1 unit(s)

Package 3 of 5

PCID:

Description:
Förfylld spruta, 2 st

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 1 Syringe

Package: 1 Box (Cardboard)

Containing:

Package: 2 Unit-dose blister (Plastic)

Containing:

Package: 1 Pre-filled syringe (Glass)

Containing: 1 Syringe

Manufactured Item

Dose form: Solution for injection

Unit of presentation: Syringe

Ingredient

Role: Active

Substance: dalteparin sodium

Concentration strength: quantity sufficient / 1 unit(s)

Reference strength:
dalteparin 5000 international unit(s) / 1 unit(s)

Package 4 of 5

PCID:

Description:
Förfylld spruta, 25 st

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 1 Syringe

Package: 1 Box (Cardboard)

Containing:

Package: 25 Unit-dose blister (Plastic)

Containing:

Package: 1 Pre-filled syringe (Glass)

Containing: 1 Syringe

Manufactured Item

Dose form: Solution for injection

Unit of presentation: Syringe

Ingredient

Role: Active

Substance: dalteparin sodium

Concentration strength: quantity sufficient / 1 unit(s)

Reference strength:
dalteparin 5000 international unit(s) / 1 unit(s)

Package 5 of 5

PCID:

Description:
Förfylld spruta, 5 st

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 1 Syringe

Package: 1 Box (Cardboard)

Containing:

Package: 25 Unit-dose blister (Plastic)

Containing:

Package: 1 Pre-filled syringe (Glass)

Containing: 1 Syringe

Manufactured Item

Dose form: Solution for injection

Unit of presentation: Syringe

Ingredient

Role: Active

Substance: dalteparin sodium

Concentration strength: quantity sufficient / 1 unit(s)

Reference strength:
dalteparin 5000 international unit(s) / 1 unit(s)

Administrable Product (1 of 1)

Dose form: Solution for injection

Unit of presentation:

Route of administration:

  • Intravenous use
  • Subcutaneous use
  • Extracorporeal use

Ingredients:

Ingredient

Role: Active

Substance: dalteparin sodium

Concentration strength: quantity sufficient / 1 unit(s)

Reference strength:
dalteparin 5000 international unit(s) / 1 unit(s)